STAGE 1-3

Clinical trials for STAGE 1-3 explained in plain language.

Never miss a new study

Get alerted when new STAGE 1-3 trials appear

Sign up with your email to follow new studies for STAGE 1-3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to wipe out breast cancer before surgery

Disease control Not yet recruiting

This study tests whether adding an immune-boosting drug called eftilagimod alpha to standard chemotherapy before surgery can completely eliminate tumors in people with early-stage hormone receptor-positive, HER2-negative breast cancer. About 50 participants will receive the drug …

Matched conditions: STAGE 1-3

Phase: PHASE2 • Sponsor: George Washington University • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

STAGE 1-3

Get alerted when new STAGE 1-3 trials appear

New combo therapy aims to wipe out breast cancer before surgery